Earnings release · CVS
CVS HEALTH Corp · Filed · SEC Form 8-K, Item 2.02
Revenue increased 7.3% year on year to $106.1 billion, and EPS was $2.31. Management raised its outlook, and guidance changes often matter more to the market than the quarter just reported because they reflect expectations for the periods ahead.
Written automatically by Stocknote's note engine from the figures on this page and the company's previous release. Every number in this note is checked against those figures. Not investment advice.
$106.1 billion +7.3% vs a year ago
…Second quarter total revenues increased to $106.1 billion, up 7.3% year-over-year…
$2.31
…Second quarter GAAP diluted EPS of $2.31 and Adjusted EPS of $2.58…
Guidance raised
…AND RAISES FULL-YEAR 2026 GUIDANCE | Raising full-year 2026 guidance:…
CVS Health's Q1 2026 Aetna medical benefit ratio of 84.6% and five consecutive earnings beats confirm the turnaround is structural, not seasonal. Caremark's 11% revenue growth and 200bps GLP-1 share gain are the hidden growth engine.
Forensic equity research on US stocks. No spam, unsubscribe anytime.
